In the fast-paced realm of preclinical research, biotechnology, and molecular biochemistry, time is a premium asset. Research timelines are tightly calculated, funding cycles are strictly bounded, and biological assets such as specialized cell lines or tissue cultures—have rigid operational windows. When an active assay is scheduled, laboratory technicians must have absolute confidence...
